JAN PRUSINOWSKI: Open Payments
NPI 1366413411 · WYANDOTTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 27 payments from 11 companies in 2025. Trend: 2023 $586 · 2024 $378 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $238 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| Organon LLC | 5 | $67 |
| LEO Pharma Inc. | 3 | $54 |
| Janssen Biotech, Inc. | 2 | $41 |
| Incyte Corporation | 1 | $29 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
| Galderma Laboratories, L.P. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
Products named: Bimzelx, DUPIXENT, TREMFYA, VTAMA, ADBRY, OPZELURA, Zoryve, NEMLUVIO.
Industry payments across MI — which companies pay providers there.
